ORAMED PHARMACEUTICALS INC. Total Long-Term Debt
ORAMED PHARMACEUTICALS INC. (ORMP) had Total Long-Term Debt of $74.55 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2023-11-09
- 2023-09-30: Long-term Debt $74.55M.
- 2022-12-31: Long-term Debt $25.00K.
- 2022-09-30: Long-term Debt $5.23M.
- 2022-06-30: Long-term Debt $7.31M.
| Period end | Long-term Debt |
|---|---|
| 2023-09-30 | $74.55M 10-Q · filed 2023-11-09 |
| 2022-12-31 | $25.00K 10-K · filed 2023-03-06 |
| 2022-09-30 | $5.23M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $7.31M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $9.23M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $11.62M 10-Q · filed 2022-11-10 |
| 2021-11-30 | $11.70M 10-Q · filed 2022-01-11 |
| 2021-08-31 | $12.54M 10-QT · filed 2022-03-30 |
| 2019-08-31 | $9.66M 10-K · filed 2019-11-27 |
| 2018-08-31 | $11.39M 10-K · filed 2019-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |